×

Contract Research and Manufacturing Service CRAMS Market Size, Share, Trends, Growth Outlook

Contract Research and Manufacturing Service (CRAMS) Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Service (Manufacturing, Research), By Therapeutic Area (Cardiovascular, Infectious disease, Endocrine disease, Oncology, Gastrointestinal and others), By End-User (Pharmaceutical companies, Medical device companies, Academic and research institutes), Countries and Companies Report

  • Home
  • Healthcare
  • Contract Research and Manufacturing Service CRAMS Market
  • |Published Month : May, 2024
  • |No. of Pages : 204

Global Contract Research and Manufacturing Service (CRAMS) Market Size is Valued at $243 Million in 2024 and is forecast to register a growth rate (CAGR) of 9.6% to reach $505.9 Million by 2032.

The global Contract Research and Manufacturing Service (CRAMS) Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Service (Manufacturing, Research), By Therapeutic Area (Cardiovascular, Infectious disease, Endocrine disease, Oncology, Gastrointestinal and others), By End-User (Pharmaceutical companies, Medical device companies, Academic and research institutes)

An Introduction to Contract Research and Manufacturing Service (CRAMS) Market

The CRAMS market is witnessing significant growth as pharmaceutical and biotechnology companies increasingly outsource research and manufacturing activities to specialized service providers. CRAMS offers a cost-effective and efficient solution for drug development, clinical trials, and large-scale manufacturing, allowing companies to focus on core competencies and accelerate time-to-market for new therapies. The market growth is driven by the rising R&D expenditure, the complexity of modern drug development, and the demand for flexible, scalable manufacturing capabilities.

Contract Research and Manufacturing Service (CRAMS) Market Competitive Landscape

The market report analyses the leading companies in the industry including Aragen Life Sciences Pvt. Ltd, Arch Pharmalabs Ltd, Aurobindo Pharma Ltd, BHAGWATI ORGANICS PVT. Ltd, Biocon Ltd, Dhanuka Agritech Ltd, Dishman Carbogen Amcis Ltd, Divis Laboratories Ltd, Ind Swift Laboratories Ltd, Ipca Laboratories Ltd, Jubilant Pharmova Ltd, Lupin Ltd, Merck and Co. Inc, MSN Laboratories, Murli Krishna Pharma, Piramal Enterprises Ltd, Solara, Sun Pharmaceutical Industries Ltd, TCG Lifesciences Pvt. Ltd, Wockhardt Ltd, and others.

Contract Research and Manufacturing Service (CRAMS) Market Dynamics

Contract Research and Manufacturing Service (CRAMS) Market Trend: Rise in Outsourcing of Pharmaceutical R&D and Manufacturing

A significant trend in the Contract Research and Manufacturing Service (CRAMS) Market is the increasing outsourcing of pharmaceutical research and manufacturing activities by biopharmaceutical companies. With the growing complexity of drug development processes, cost pressures, and the need for specialized expertise, pharmaceutical companies are increasingly turning to contract research and manufacturing organizations (CROs/CMOs) to outsource various aspects of drug discovery, development, and production. This trend reflects a strategic shift towards leveraging external expertise, infrastructure, and resources to accelerate drug development timelines, reduce operational costs, and enhance flexibility in adapting to changing market dynamics.

Contract Research and Manufacturing Service (CRAMS) Market Driver: Demand for Streamlined Drug Development and Manufacturing Processes

The demand for streamlined drug development and manufacturing processes serves as a key driver propelling the growth of the Contract Research and Manufacturing Service (CRAMS) Market. Biopharmaceutical companies are under increasing pressure to bring innovative therapies to market faster and more efficiently, necessitating the optimization of R&D and manufacturing operations. Outsourcing to CRAMS providers enables companies to access specialized capabilities, state-of-the-art facilities, and scalable production capacities, allowing them to expedite the drug development process, mitigate risks, and focus on core competencies. This driver underscores the critical role of CRAMS in enabling biopharmaceutical companies to navigate the complexities of drug development and manufacturing while maintaining competitiveness in the market.

Contract Research and Manufacturing Service (CRAMS) Market Opportunity: Expansion of Biologics Development and Manufacturing Services

An emerging opportunity within the Contract Research and Manufacturing Service (CRAMS) Market lies in the expansion of biologics development and manufacturing services. With the increasing focus on biopharmaceuticals and the growing pipeline of biologic therapies, there is a rising demand for specialized expertise and infrastructure to support biologics development, manufacturing, and commercialization. CRAMS providers have the opportunity to invest in bioprocessing capabilities, including cell culture, purification, and analytics, to cater to the unique requirements of biologic drug candidates. By offering end-to-end solutions for biologics development, from cell line development to cGMP manufacturing, CRAMS providers can capitalize on the growing demand for biopharmaceutical outsourcing and position themselves as strategic partners in the development and production of innovative biologic therapies. This presents a promising avenue for market expansion and differentiation, as biologics continue to drive growth and innovation in the pharmaceutical industry.
Contract Research and Manufacturing Service (CRAMS) Market Share Analysis: Manufacturing service generated the highest revenue in 2024The Manufacturing service segment emerges as the largest in the Contract Research and Manufacturing Service (CRAMS) Market, underscoring the significant reliance on outsourced manufacturing capabilities by pharmaceutical and biotechnology companies. This dominance reflects the industry's strategic outsourcing of manufacturing activities to specialized contract service providers to streamline operations, mitigate costs, and enhance flexibility in production processes. As pharmaceutical companies seek to optimize resource allocation, accelerate time-to-Market, and navigate complex regulatory landscapes, outsourcing manufacturing services enables them to focus on core competencies while leveraging the expertise and infrastructure of contract service providers. With an increasing emphasis on efficiency, quality, and scalability in drug manufacturing, the demand for contract manufacturing services continues to drive Market growth, shaping the landscape of the global pharmaceutical and biotechnology industries.Contract Research and Manufacturing Service (CRAMS) Market Share Analysis: Oncology is poised to register the fastest CAGR over the forecast period to 2030The Oncology segment emerges as the fastest-growing segment in the Contract Research and Manufacturing Service (CRAMS) Market, poised for significant expansion by 2030. This trend reflects the escalating demand for outsourced research and manufacturing services in the field of oncology, driven by the increasing prevalence of cancer worldwide and the growing pipeline of oncology therapeutics in development. As pharmaceutical and biotechnology companies intensify their efforts to discover and develop innovative cancer treatments, they increasingly rely on contract service providers to accelerate drug development timelines, navigate regulatory complexities, and access specialized expertise in oncology research and manufacturing. With oncology emerging as a pivotal therapeutic area in healthcare, the demand for contract research and manufacturing services tailored to meet the unique needs of oncology drug development continues to surge, driving Market growth and shaping the future of cancer care.Contract Research and Manufacturing Service (CRAMS) Market Share Analysis: Pharmaceutical Companies generated the highest revenue in 2024The Pharmaceutical Companies segment emerges as the largest in the Contract Research and Manufacturing Service (CRAMS) Market, reflecting the substantial reliance of pharmaceutical companies on outsourced research and manufacturing services to streamline drug development processes and enhance operational efficiency. This dominance underscores the strategic outsourcing partnerships established by pharmaceutical companies with contract service providers to access specialized expertise, state-of-the-art facilities, and cost-effective solutions across the drug development lifecycle. As pharmaceutical companies strive to accelerate time-to-Market, optimize resource allocation, and navigate evolving regulatory landscapes, outsourcing research and manufacturing activities enables them to focus on core competencies while leveraging the capabilities of contract service providers. With an increasing emphasis on innovation, quality, and competitiveness in the pharmaceutical industry, the demand for contract research and manufacturing services from pharmaceutical companies continues to drive Market growth, shaping the landscape of the global pharmaceutical sector.

Contract Research and Manufacturing Service (CRAMS) Market Report Segmentation

By Service
Manufacturing
Research
By Therapeutic Area
Cardiovascular
Infectious disease
Endocrine disease
Oncology
Gastrointestinal and others
By End-User
Pharmaceutical companies
Medical device companies
Academic and research institutes
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Contract Research and Manufacturing Service (CRAMS) Market Companies Profiled in the Study

Aragen Life Sciences Pvt. Ltd
Arch Pharmalabs Ltd
Aurobindo Pharma Ltd
BHAGWATI ORGANICS PVT. Ltd
Biocon Ltd
Dhanuka Agritech Ltd
Dishman Carbogen Amcis Ltd
Divis Laboratories Ltd
Ind Swift Laboratories Ltd
Ipca Laboratories Ltd
Jubilant Pharmova Ltd
Lupin Ltd
Merck and Co. Inc
MSN Laboratories
Murli Krishna Pharma
Piramal Enterprises Ltd
Solara
Sun Pharmaceutical Industries Ltd
TCG Lifesciences Pvt. Ltd
Wockhardt Ltd
*- List Not Exhaustive

TABLE OF CONTENTS

1 Introduction to 2024 Contract Research and Manufacturing Service (CRAMS) Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Contract Research and Manufacturing Service (CRAMS) Market Size Outlook, $ Million, 2021 to 2030
3.2 Contract Research and Manufacturing Service (CRAMS) Market Outlook by Type, $ Million, 2021 to 2030
3.3 Contract Research and Manufacturing Service (CRAMS) Market Outlook by Product, $ Million, 2021 to 2030
3.4 Contract Research and Manufacturing Service (CRAMS) Market Outlook by Application, $ Million, 2021 to 2030
3.5 Contract Research and Manufacturing Service (CRAMS) Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Contract Research and Manufacturing Service (CRAMS) Industry
4.2 Key Market Trends in Contract Research and Manufacturing Service (CRAMS) Industry
4.3 Potential Opportunities in Contract Research and Manufacturing Service (CRAMS) Industry
4.4 Key Challenges in Contract Research and Manufacturing Service (CRAMS) Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Contract Research and Manufacturing Service (CRAMS) Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Contract Research and Manufacturing Service (CRAMS) Market Outlook by Segments
7.1 Contract Research and Manufacturing Service (CRAMS) Market Outlook by Segments, $ Million, 2021- 2030
By Service
Manufacturing
Research
By Therapeutic Area
Cardiovascular
Infectious disease
Endocrine disease
Oncology
Gastrointestinal and others
By End-User
Pharmaceutical companies
Medical device companies
Academic and research institutes

8 North America Contract Research and Manufacturing Service (CRAMS) Market Analysis and Outlook To 2030
8.1 Introduction to North America Contract Research and Manufacturing Service (CRAMS) Markets in 2024
8.2 North America Contract Research and Manufacturing Service (CRAMS) Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Contract Research and Manufacturing Service (CRAMS) Market size Outlook by Segments, 2021-2030
By Service
Manufacturing
Research
By Therapeutic Area
Cardiovascular
Infectious disease
Endocrine disease
Oncology
Gastrointestinal and others
By End-User
Pharmaceutical companies
Medical device companies
Academic and research institutes

9 Europe Contract Research and Manufacturing Service (CRAMS) Market Analysis and Outlook To 2030
9.1 Introduction to Europe Contract Research and Manufacturing Service (CRAMS) Markets in 2024
9.2 Europe Contract Research and Manufacturing Service (CRAMS) Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Contract Research and Manufacturing Service (CRAMS) Market Size Outlook by Segments, 2021-2030
By Service
Manufacturing
Research
By Therapeutic Area
Cardiovascular
Infectious disease
Endocrine disease
Oncology
Gastrointestinal and others
By End-User
Pharmaceutical companies
Medical device companies
Academic and research institutes

10 Asia Pacific Contract Research and Manufacturing Service (CRAMS) Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Contract Research and Manufacturing Service (CRAMS) Markets in 2024
10.2 Asia Pacific Contract Research and Manufacturing Service (CRAMS) Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Contract Research and Manufacturing Service (CRAMS) Market size Outlook by Segments, 2021-2030
By Service
Manufacturing
Research
By Therapeutic Area
Cardiovascular
Infectious disease
Endocrine disease
Oncology
Gastrointestinal and others
By End-User
Pharmaceutical companies
Medical device companies
Academic and research institutes

11 South America Contract Research and Manufacturing Service (CRAMS) Market Analysis and Outlook To 2030
11.1 Introduction to South America Contract Research and Manufacturing Service (CRAMS) Markets in 2024
11.2 South America Contract Research and Manufacturing Service (CRAMS) Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Contract Research and Manufacturing Service (CRAMS) Market size Outlook by Segments, 2021-2030
By Service
Manufacturing
Research
By Therapeutic Area
Cardiovascular
Infectious disease
Endocrine disease
Oncology
Gastrointestinal and others
By End-User
Pharmaceutical companies
Medical device companies
Academic and research institutes

12 Middle East and Africa Contract Research and Manufacturing Service (CRAMS) Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Contract Research and Manufacturing Service (CRAMS) Markets in 2024
12.2 Middle East and Africa Contract Research and Manufacturing Service (CRAMS) Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Contract Research and Manufacturing Service (CRAMS) Market size Outlook by Segments, 2021-2030
By Service
Manufacturing
Research
By Therapeutic Area
Cardiovascular
Infectious disease
Endocrine disease
Oncology
Gastrointestinal and others
By End-User
Pharmaceutical companies
Medical device companies
Academic and research institutes

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
Aragen Life Sciences Pvt. Ltd
Arch Pharmalabs Ltd
Aurobindo Pharma Ltd
BHAGWATI ORGANICS PVT. Ltd
Biocon Ltd
Dhanuka Agritech Ltd
Dishman Carbogen Amcis Ltd
Divis Laboratories Ltd
Ind Swift Laboratories Ltd
Ipca Laboratories Ltd
Jubilant Pharmova Ltd
Lupin Ltd
Merck and Co. Inc
MSN Laboratories
Murli Krishna Pharma
Piramal Enterprises Ltd
Solara
Sun Pharmaceutical Industries Ltd
TCG Lifesciences Pvt. Ltd
Wockhardt Ltd

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Service
Manufacturing
Research
By Therapeutic Area
Cardiovascular
Infectious disease
Endocrine disease
Oncology
Gastrointestinal and others
By End-User
Pharmaceutical companies
Medical device companies
Academic and research institutes

Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Frequently Asked Questions

Related Reports